University Hospitals Receives $14.5 Million In New Gifts
This is Mrs. Coleman's third major investment in UH's cancer clinical trials program. In 2001, she made a $1.5 million endowed gift to establish the Dr. Lester E. Coleman, Jr. Chair in Cancer Research and Therapeutics. Mrs. Coleman further honored her husband's legacy in 2007 by making an additional $1.5 million gift to complete a vital capital project: the Kathleen A. and Dr. Lester E. Coleman Clinical Research Suite at Seidman Cancer Center, a leading-edge clinical trials patient unit featuring inpatient beds for clinical trials, along with a control room for cell processing and diagnostics. Through her advocacy and personal support, as part of the Discover the Difference Campaign, Mrs. Coleman is currently leading a $15 million campaign aimed at advancing cancer clinical trials.
"The Colemans have done so much to advance cancer care, from Les' participation in a clinical trial to Kathy's generosity and volunteer leadership at Seidman Cancer Center," said Nathan Levitan, MD, President, UH Seidman Cancer Center. "This new gift will enable us to build upon our long legacy of being at the forefront of cancer research and will have a tremendous impact on achieving our goal: Curing Cancer Every Day."
As one of the nation's leaders in clinical research, Seidman Cancer Center is dedicated to innovative treatments and clinical research through more than 300 ongoing studies aimed at cancer treatment and prevention. As part of the Case Comprehensive Cancer Center at Case Western Reserve University, Seidman Cancer Center is also one of only seven centers in the nation with National Cancer Institute (NCI)-designated Phase I and Phase II trials with new drugs.
"Les and I were so grateful for the care he received at Seidman Cancer Center and he enjoyed a greater quality of life through participating in the clinical trials program," said Mrs. Coleman. "This gift honors his lifelong commitment to advancing science and I am so excited to support the advancement of clinical trials which will have a profound impact on patients today and for generations to come."
Check Out Our Best Services for Investors
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Model portfolio
- Stocks trading below $10
- Intraday trade alerts